University of Alberta
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alberta sits in the top decile of US sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count).
University of Alberta: 19 sponsored US clinical trials, 15 recruiting.
University of Alberta sponsors 19 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 2 completed. 1 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Subarachnoid Hemorrhage, Aneurysmal, with 2 trials.
Top-decile sponsor footprint
University of Alberta ranks in the top decile of sponsors by registered trial count (#772 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
19 total, page 1 of 1
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
NCT06626022
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
NCT06446739
Nimodipine Variability in SAH
NCT07065903
Trifecta-Lung cfDNA-MMDx Study
NCT05837663
Micro-UltraSound In Cancer - Active Surveillance
NCT05558241
Augmented Renal Clearance in Neurocritical Care
NCT07410624
Trifecta-Heart cfDNA-MMDx Study
NCT04707872
Effects of 5HTP on the Injured Human Spinal Cord
NCT04520178
Trifecta-Kidney cfDNA-MMDx Study
NCT04239703
Diagnostic and Therapeutic Applications of Microarrays in Liver Transplantation
NCT03193151
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
NCT03362658
Diagnostic and Therapeutic Applications of Microarrays in Lung Transplantation
NCT02812290
Effectiveness of Robotic Gait Training and Physical Therapy for Children and Youth With Cerebral Palsy
NCT02391324
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
NCT02670408
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168
Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative
NCT03910933
International Nutrition Audit in FORegut TuMors
NCT02829489
Risk Factors for Coronary Artery Calcification and Left Ventricular Hypertrophy in Hemodialysis Patients
NCT01427374
Study of Combivir for Patients With Primary Biliary Cirrhosis
NCT00490620
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 2 |
| Phase 3 | 1 |
What is open in the University of Alberta pipeline
15 recruiting of 19 indexed (79% open); 2 completed (11%).
Phase mix: 1 late (III/IV) vs 2 early (I/II) (early-phase heavy).
Top condition: Subarachnoid Hemorrhage, Aneurysmal (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alberta: open-pipeline peers nationwide
Peers matched on 19 registered trials and 79% open enrollment, not the therapeutic-area sidebar.
University of Alberta sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 19 trials (± recruiting share)
- Almirall, S.A. · 19 trials · 5% recruiting
- Bastyr University · 19 trials · 11% recruiting
- Church & Dwight Company · 19 trials · 0% recruiting
- Cordis US · 19 trials · 5% recruiting
Sponsors near 79% open enrollment (± trial volume)
- BeOne Medicines · 79% recruiting · 29 trials
- Alpha Tau Medical · 80% recruiting · 5 trials
- Buck Institute for Research on Aging · 80% recruiting · 5 trials
- IDEAYA Biosciences · 80% recruiting · 10 trials
Related
What to do with this University of Alberta page
19 registered trials is a research-attention snapshot, not an endorsement of University of Alberta or any single study.
- 15 of University of Alberta's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Subarachnoid Hemorrhage, Aneurysmal is the condition University of Alberta studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Subarachnoid Hemorrhage, Aneurysmal trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Alberta pipeline card: 19 registered trials from official public datasets.Report a data error.